Guided Therapeutics, Inc. (GTHP)
USD 0.08
(0.0%)
USD 0.08
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 511 Thousand USD | -62.84% |
| 2022 | 1.37 Million USD | -21.83% |
| 2021 | 1.75 Million USD | 73.3% |
| 2020 | 1.01 Million USD | 65.58% |
| 2019 | 613 Thousand USD | 80.29% |
| 2018 | 340 Thousand USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | -100.0% |
| 2014 | 823 Thousand USD | 699.03% |
| 2013 | 103 Thousand USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 4000.00 USD | -87.1% |
| 2010 | 31 Thousand USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 3.58 Million USD | 68.77% |
| 2007 | 2.12 Million USD | 10.34% |
| 2006 | 1.92 Million USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | -100.0% |
| 1997 | 300 Thousand USD | 0.0% |
| 1996 | 300 Thousand USD | 0.0% |
| 1995 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 34 Thousand USD | -93.35% |
| 2024 Q2 | 82 Thousand USD | 141.18% |
| 2023 FY | 511 Thousand USD | -62.84% |
| 2023 Q1 | 1.74 Million USD | 26.84% |
| 2023 Q2 | 727 Thousand USD | -58.31% |
| 2023 Q3 | 693 Thousand USD | -4.68% |
| 2023 Q4 | 511 Thousand USD | -26.26% |
| 2022 Q1 | 1.72 Million USD | -1.82% |
| 2022 FY | 1.37 Million USD | -21.83% |
| 2022 Q2 | 1.27 Million USD | -26.29% |
| 2022 Q3 | 1.37 Million USD | 8.09% |
| 2022 Q4 | 1.37 Million USD | -0.07% |
| 2021 Q2 | 1.69 Million USD | 77.07% |
| 2021 Q1 | 955 Thousand USD | -5.91% |
| 2021 Q3 | 1.71 Million USD | 1.48% |
| 2021 FY | 1.75 Million USD | 73.3% |
| 2021 Q4 | 1.75 Million USD | 2.51% |
| 2020 FY | 1.01 Million USD | 65.58% |
| 2020 Q1 | 689 Thousand USD | 12.4% |
| 2020 Q2 | 1.15 Million USD | 68.21% |
| 2020 Q3 | 1.26 Million USD | 9.06% |
| 2020 Q4 | 1.01 Million USD | -19.7% |
| 2019 Q1 | 405 Thousand USD | 19.12% |
| 2019 Q4 | 613 Thousand USD | -2.23% |
| 2019 Q3 | 627 Thousand USD | 0.48% |
| 2019 Q2 | 624 Thousand USD | 54.07% |
| 2019 FY | 613 Thousand USD | 80.29% |
| 2018 FY | 340 Thousand USD | 0.0% |
| 2018 Q3 | 606 Thousand USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q4 | 340 Thousand USD | -43.89% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q2 | - USD | -100.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q1 | 197 Thousand USD | 0.0% |
| 2015 Q1 | 795 Thousand USD | -3.4% |
| 2015 Q2 | 1.02 Million USD | 29.31% |
| 2015 Q3 | - USD | -100.0% |
| 2015 FY | - USD | -100.0% |
| 2015 Q4 | - USD | 0.0% |
| 2014 Q4 | 823 Thousand USD | -64.2% |
| 2014 FY | 823 Thousand USD | 699.03% |
| 2014 Q2 | 2.75 Million USD | 2678.79% |
| 2014 Q1 | 99 Thousand USD | -3.88% |
| 2014 Q3 | 2.29 Million USD | -16.43% |
| 2013 Q2 | 157 Thousand USD | -14.21% |
| 2013 FY | 103 Thousand USD | 0.0% |
| 2013 Q3 | 135 Thousand USD | -14.01% |
| 2013 Q1 | 183 Thousand USD | 0.0% |
| 2013 Q4 | 103 Thousand USD | -23.7% |
| 2012 Q1 | - USD | -100.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | -100.0% |
| 2012 Q3 | - USD | 0.0% |
| 2011 FY | 4000.00 USD | -87.1% |
| 2011 Q4 | 4000.00 USD | -63.64% |
| 2011 Q3 | 11 Thousand USD | -35.29% |
| 2011 Q2 | 17 Thousand USD | -67.92% |
| 2011 Q1 | 53 Thousand USD | 70.97% |
| 2010 FY | 31 Thousand USD | 0.0% |
| 2010 Q4 | 31 Thousand USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | -100.0% |
| 2009 Q1 | 4.38 Million USD | 22.3% |
| 2009 Q2 | 4.93 Million USD | 12.6% |
| 2009 Q3 | - USD | -100.0% |
| 2008 Q3 | 2.89 Million USD | 12.62% |
| 2008 Q4 | 3.58 Million USD | 23.94% |
| 2008 FY | 3.58 Million USD | 68.77% |
| 2008 Q2 | 2.56 Million USD | 8.08% |
| 2008 Q1 | 2.37 Million USD | 11.87% |
| 2007 Q3 | 2.04 Million USD | 0.0% |
| 2007 Q4 | 2.12 Million USD | 3.92% |
| 2007 Q1 | - USD | -100.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 FY | 2.12 Million USD | 10.34% |
| 2006 Q3 | - USD | 0.0% |
| 2006 FY | 1.92 Million USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | 1.92 Million USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q4 | - USD | -100.0% |
| 2000 Q3 | 381 Thousand USD | 0.0% |
| 2000 Q2 | 381 Thousand USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 FY | - USD | -100.0% |
| 1998 Q1 | 300 Thousand USD | 0.0% |
| 1998 Q2 | - USD | -100.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1997 FY | 300 Thousand USD | 0.0% |
| 1997 Q2 | 300 Thousand USD | 0.0% |
| 1997 Q4 | 300 Thousand USD | 0.0% |
| 1997 Q3 | 300 Thousand USD | 0.0% |
| 1997 Q1 | 300 Thousand USD | 20.0% |
| 1996 FY | 300 Thousand USD | 0.0% |
| 1996 Q4 | 250 Thousand USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 12.52 Million USD | 95.922% |
| IR-Med Inc. | 161 Thousand USD | -217.391% |
| Polarean Imaging plc | 74.84 Thousand USD | -582.735% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | -340.312% |
| Avitar, Inc. | 3.89 Million USD | 86.886% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -13.686% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | 99.836% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | 97.291% |
| Össur hf. | 311.8 Million USD | 99.836% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | 17.314% |
| Escalon Medical Corp. | 279.4 Thousand USD | -82.889% |
| Aurora Spine Corporation | 1.59 Million USD | 67.898% |
| BrainsWay Ltd. | 239 Thousand USD | -113.808% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 16.7 Million USD | 96.941% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | 99.937% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | -134.823% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | -1069.979% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | 13.39% |
| Nanomix Corporation | 10.11 Million USD | 94.946% |
| Theraclion SA | 1.95 Million EUR | 73.805% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | -67.761% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | -240.667% |
| Lombard Medical, Inc. | 28.02 Million USD | 98.177% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | 99.427% |
| Vycor Medical, Inc. | 243.28 Thousand USD | -110.04% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -259.027% |
| SANUWAVE Health, Inc. | 492 Thousand USD | -3.862% |
| VMS Rehab Systems, Inc. | 106.45 USD | -479937.576% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | 3.997% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 804 Thousand USD | 36.443% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | -58.498% |
| Urologix, Inc. | 4.58 Million USD | 88.857% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | -18.772% |
| Nexeon MedSystems Inc. | 2.78 Million USD | 81.66% |
| SS Innovations International, Inc. | 1.91 Million USD | 73.252% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.17 Billion USD | 99.976% |
| NIOX Group Plc | 500 Thousand USD | -2.2% |
| Fuse Medical, Inc. | 200 Thousand USD | -155.5% |
| Broncus Holding Corporation | 1.22 Million USD | 58.252% |
| Brain Scientific Inc. | 7378.00 USD | -6825.996% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | -215.697% |
| Health Logic Interactive Inc. | - USD | -Infinity% |